Literature DB >> 9725196

Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens.

S A Minskoff1, K Matter, I Mellman.   

Abstract

Fc gamma receptors (Fc gamma RII) on B lymphocytes negatively regulate B cell receptor (BCR)-dependent activation upon cross-linking of the two receptors. The mechanism reflects the ability of the Fc gamma RII cytoplasmic tail to recruit specific phosphatases that inactivate elements of the BCR-signaling cascade. We now show that cross-linking also blocks the processing and presentation of BCR-bound Ag. This occurs because the Fc gamma RII isoform typically expressed by B cells (Fc gamma RII-B1) is incompetent for endocytosis. When cross-linked, Fc gamma RII-B1 acts as a dominant negative inhibitor of BCR endocytosis. In contrast, cross-linking of endocytosis-competent Fc gamma RII isoforms did not inhibit endocytosis or processing of BCR-bound Ag. Thus, Fc gamma RII-B1 acts not only to prevent B cell activation under conditions of Ab excess, but also to prevent clonotypic T cell activation by inhibiting the ability of B cells to generate specific MHC class II-bound TCR ligands.

Mesh:

Substances:

Year:  1998        PMID: 9725196

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

2.  Immunoglobulin heavy chain constant regions regulate immunity and tolerance to idiotypes of antibody variable regions.

Authors:  Solveig Klaebo Reitan; Kristian Hannestad
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

3.  Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.

Authors:  Judith M H de Jong; Danita H Schuurhuis; Andreea Ioan-Facsinay; Mick M Welling; Marcel G M Camps; Ellen I H van der Voort; Tom W J Huizinga; Ferry Ossendorp; J Sjef Verbeek; René E M Toes
Journal:  Immunology       Date:  2006-09-21       Impact factor: 7.397

Review 4.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

5.  Visualization of negative signaling in B cells by quantitative confocal microscopy.

Authors:  H Phee; W Rodgers; K M Coggeshall
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  Function and regulation of self-reactive marginal zone B cells in autoimmune arthritis.

Authors:  Anna-Karin E Palm; Heike C Friedrich; Anja Mezger; Maya Salomonsson; Linda K Myers; Sandra Kleinau
Journal:  Cell Mol Immunol       Date:  2015-05-11       Impact factor: 11.530

8.  Gene expression versus sequence for predicting function: Glia Maturation Factor gamma is not a glia maturation factor.

Authors:  Michael G Walker
Journal:  Genomics Proteomics Bioinformatics       Date:  2003-02       Impact factor: 7.691

9.  Regulation of allograft survival by inhibitory FcγRIIb signaling.

Authors:  Chris J Callaghan; Thet Su Win; Reza Motallebzadeh; Thomas M Conlon; Manu Chhabra; Inês Harper; Siva Sivaganesh; Eleanor M Bolton; J Andrew Bradley; Rebecca J Brownlie; Kenneth G C Smith; Gavin J Pettigrew
Journal:  J Immunol       Date:  2012-11-12       Impact factor: 5.422

10.  FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.

Authors:  Menna R Clatworthy; Kenneth G C Smith
Journal:  J Exp Med       Date:  2004-02-23       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.